GAO-14-68, Medicaid Prescription Drugs: CMS Should Implement Revised Federal Upper Limits and Monitor Their Relationship to Retail Pharmacy Acquisition Costs [Reissued on February 6, 2014]

First Page		Document Content
Date: 2014-02-06 15:10:22 Pharmacology Pharmaceuticals policy Federal assistance in the United States Healthcare reform in the United States Presidency of Lyndon B. Johnson Medicaid Patient Protection and Affordable Care Act Pharmacy benefit management Medicare Health Pharmaceutical sciences Medicine		GAO-14-68, Medicaid Prescription Drugs: CMS Should Implement Revised Federal Upper Limits and Monitor Their Relationship to Retail Pharmacy Acquisition Costs [Reissued on February 6, 2014] Add to Reading List Source URL: www.gao.gov Download Document from Source Website File Size: 1,18 MB Share Document on Facebook

	Centers for Medicare & Medicaid Services, HHS from the clinic or center and the conditions for release of information. (3) The patient’s written consent is required for release of information not authorized to be relea DocID: 1xTVP - View Document
	Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information DocID: 1xTu9 - View Document
	PDF Document DocID: 1xMyA - View Document
	PDF Document DocID: 1xH5S - View Document
	PDF Document DocID: 1xBUn - View Document